Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]

Lisanwork Arage L, Deybasso HA, Yilma Gebremichael D, Gintamo Nuramo B, Negash Mekuria Z. HIV AIDS (Auckl). 2021;13:307–314.The Editor-in-chief and Publisher of HIV/AIDS – Research and Palliative Care wish to retract the published article. Foll...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lisanwork Arage L, Deybasso HA, Yilma Gebremichael D, Gintamo Nuramo B, Negash Mekuria Z
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	isoniazid and rifapentine tpt hepatotoxicity hiv patients ethiopia Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/b5af5bbb13444b469ef48394ccebe886
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b5af5bbb13444b469ef48394ccebe886
record_format	dspace
spelling	oai:doaj.org-article:b5af5bbb13444b469ef48394ccebe8862021-12-02T15:40:18ZDeterminants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]1179-1373https://doaj.org/article/b5af5bbb13444b469ef48394ccebe8862021-04-01T00:00:00Zhttps://www.dovepress.com/retraction-determinants-of-drug-induced-hepatotoxicity-among-patients--peer-reviewed-fulltext-article-HIVhttps://doaj.org/toc/1179-1373Lisanwork Arage L, Deybasso HA, Yilma Gebremichael D, Gintamo Nuramo B, Negash Mekuria Z. HIV AIDS (Auckl). 2021;13:307–314.The Editor-in-chief and Publisher of HIV/AIDS – Research and Palliative Care wish to retract the published article. Following publication, the journal was notified that the data for this article was taken from a study funded by USAID and sponsored by the KNCV/Aurum Institute as part of a multi-country clinical trial conducted in South Africa, Mozambique and Ethiopia. The data presented in the article was used by the authors without authorization from the data owners. It also came to the journal’s attention that aside from the first author, none of the remaining authors listed were part of the project investigation team and none were known to the principal investigator and had no involvement with the clinical trial.The authors wish to apologise for this and agree with the decision to retract the article.Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.This retraction relates to this paperLisanwork Arage LDeybasso HAYilma Gebremichael DGintamo Nuramo BNegash Mekuria ZDove Medical Pressarticleisoniazid and rifapentinetpthepatotoxicityhiv patientsethiopiaImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol Volume 13, Pp 475-476 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	isoniazid and rifapentine tpt hepatotoxicity hiv patients ethiopia Immunologic diseases. Allergy RC581-607
spellingShingle	isoniazid and rifapentine tpt hepatotoxicity hiv patients ethiopia Immunologic diseases. Allergy RC581-607 Lisanwork Arage L Deybasso HA Yilma Gebremichael D Gintamo Nuramo B Negash Mekuria Z Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
description	Lisanwork Arage L, Deybasso HA, Yilma Gebremichael D, Gintamo Nuramo B, Negash Mekuria Z. HIV AIDS (Auckl). 2021;13:307–314.The Editor-in-chief and Publisher of HIV/AIDS – Research and Palliative Care wish to retract the published article. Following publication, the journal was notified that the data for this article was taken from a study funded by USAID and sponsored by the KNCV/Aurum Institute as part of a multi-country clinical trial conducted in South Africa, Mozambique and Ethiopia. The data presented in the article was used by the authors without authorization from the data owners. It also came to the journal’s attention that aside from the first author, none of the remaining authors listed were part of the project investigation team and none were known to the principal investigator and had no involvement with the clinical trial.The authors wish to apologise for this and agree with the decision to retract the article.Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.This retraction relates to this paper
format	article
author	Lisanwork Arage L Deybasso HA Yilma Gebremichael D Gintamo Nuramo B Negash Mekuria Z
author_facet	Lisanwork Arage L Deybasso HA Yilma Gebremichael D Gintamo Nuramo B Negash Mekuria Z
author_sort	Lisanwork Arage L
title	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
title_short	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
title_full	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
title_fullStr	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
title_full_unstemmed	Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
title_sort	determinants of drug-induced hepatotoxicity among patients with human immunodeficiency virus taking a high dose of rifapentine plus isoniazid drugs at the all africa leprosy tuberculosis rehabilitation and training center in addis ababa, ethiopia [retraction]
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/b5af5bbb13444b469ef48394ccebe886
work_keys_str_mv	AT lisanworkaragel determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopiaretraction AT deybassoha determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopiaretraction AT yilmagebremichaeld determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopiaretraction AT gintamonuramob determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopiaretraction AT negashmekuriaz determinantsofdruginducedhepatotoxicityamongpatientswithhumanimmunodeficiencyvirustakingahighdoseofrifapentineplusisoniaziddrugsattheallafricaleprosytuberculosisrehabilitationandtrainingcenterinaddisababaethiopiaretraction
_version_	1718385895065780224

Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]

Ejemplares similares